choriocarcinoma. EMA/CO regimen (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine), which is widely used in gestational trophoblastic neoplasia (GTN), is usually given to primary mediastinal choriocarcinoma patients. However, due to drug resistance and heavy tumor burden, the prognosis is poor (3).Programmed cell death 1 ligand 1 (PD-L1) is ubiquitously expressed in choriocarcinoma tumors (4), indicating programmed cell death 1 (PD-1) inhibitor,